Mizutani M - Search Results

1

Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.

Fujimoto S, Koga T, Kawakami A, Kawabata H, Okamoto S, Mizuki M, Yano S, Ide M, Uno K, Yagi K, Kojima T, Mizutani M, Tokumine Y, Nishimoto N, Fujiwara H, Nakatsuka SI, Shiozawa K, Iwaki N, Masaki Y, Yoshizaki K. Fujimoto S, et al. Among authors: mizutani m. Mod Rheumatol. 2018 Jan;28(1):161-167. doi: 10.1080/14397595.2017.1366093. Epub 2017 Sep 7. Mod Rheumatol. 2018. PMID: 28880697

2

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

Ohya E, Mizutani M, Sakaguchi H, Sekine T. Ohya E, et al. Among authors: mizutani m. Intern Med. 2016;55(19):2861-2867. doi: 10.2169/internalmedicine.55.6455. Epub 2016 Oct 1. Intern Med. 2016. PMID: 27725549 Free PMC article.

3

[Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab].

Suzuki K, Ino K, Sugawara Y, Mizutani M, Sekine T, Katayama N. Suzuki K, et al. Among authors: mizutani m. Gan To Kagaku Ryoho. 2008 Apr;35(4):691-4. Gan To Kagaku Ryoho. 2008. PMID: 18408447 Japanese.

4

[A case of gastric stenosis due to primary gastric malignant lymphoma during administration of R-CHOP].

Tamai Y, Murakami E, Nakamori Y, Mizutani M, Sekine T. Tamai Y, et al. Among authors: mizutani m. Gan To Kagaku Ryoho. 2011 Aug;38(8):1371-3. Gan To Kagaku Ryoho. 2011. PMID: 21829084 Japanese.

5

[Development of syndrome of inappropriate secretion of ADH and reversible posterior leukoencephalopathy during initial rituximab-CHOP therapy in a patient with diffuse large B-cell lymphoma].

Mizutani M, Nakamori Y, Sakaguchi H, Kageyama Y, Oya E, Ino K, Suzuki K, Sekine T. Mizutani M, et al. Rinsho Ketsueki. 2013 Mar;54(3):269-72. Rinsho Ketsueki. 2013. PMID: 23676641 Japanese.

6

[Aggressive NK-cell leukemia with sustained relapse-free survival after allogeneic peripheral blood stem cell transplantation].

Ino K, Masuya M, Nakamori Y, Suzuki K, Mizutani M, Sekine T, Yamaguchi M, Nakase K, Kaida K, Ogawa H, Katayama N. Ino K, et al. Among authors: mizutani m. Rinsho Ketsueki. 2010 Apr;51(4):258-63. Rinsho Ketsueki. 2010. PMID: 20467222 Japanese.

7

[Case report: Reversible posterior leukoencephalopathy associated with the treatment of multiple myeloma: a case report].

Ohya E, Mizutani M, Sekine T. Ohya E, et al. Among authors: mizutani m. Nihon Naika Gakkai Zasshi. 2012 Jan 10;101(1):168-71. doi: 10.2169/naika.101.168. Nihon Naika Gakkai Zasshi. 2012. PMID: 22413476 Japanese. No abstract available.

8

Acquisition of JAK2 V617F to CALR-mutated clones accelerates disease progression and might enhance growth capacity.

Nishimura M, Nagaharu K, Ikejiri M, Sugimoto Y, Sasao R, Ohya E, Mizutani M, Ohishi K, Tawara I, Sekine T. Nishimura M, et al. Among authors: mizutani m. Br J Haematol. 2021 Sep;194(5):e89-e92. doi: 10.1111/bjh.17571. Epub 2021 Jun 1. Br J Haematol. 2021. PMID: 34060068 No abstract available.

9

Cup-like blasts in acute myeloid leukaemia with NPM1 and IDH2 mutations.

Ohya E, Sugimoto Y, Sasao R, Nishimura M, Mizutani M, Sekine T. Ohya E, et al. Among authors: mizutani m. EJHaem. 2021 May 6;2(3):651-652. doi: 10.1002/jha2.200. eCollection 2021 Aug. EJHaem. 2021. PMID: 35844705 Free PMC article. No abstract available.

10

[Acute myeloid leukemia invasion of the central nervous system, detected only along the Virchow Robin space].

Suzuki K, Ino K, Sugawara Y, Mizutani M, Sekine T, Katayama N. Suzuki K, et al. Among authors: mizutani m. Rinsho Ketsueki. 2008 May;49(5):340-3. Rinsho Ketsueki. 2008. PMID: 18572812 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

887 results

Search Page

Filters